CONCLUSIONS: IR-MPH was associated with short-term improvements in objective QbTest performance in adults with untreated ADHD and longstanding polysubstance use, whereas placebo effects were limited on objective outcomes and were more evident in subjective experience. These findings support the inclusion of objective assessments alongside self-report when evaluating early treatment response in clinically complex adults with ADHD and co-occurring SUD.
